Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ciclosporin plus everolimus for renal protection after heart transplantation
2006-003035-78Phase 4Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jun 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of everolimus, cyclosporine and mycophenolic acid in chronic kidney disease (CKD) and Cardiac Rejection (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Primary efficacy endpoint. Started Jun 2007; status: completed.
02
Drugs
everolimuscyclosporinemycophenolic acid
03
Conditions
chronic kidney disease (CKD)Cardiac Rejection
Beyond the preview
Go deeper on 2006-003035-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003035-78.